額外資訊
| Product No. | |
|---|---|
| Product Name | |
| Species | |
| Category | |
| Size | |
| Shipping Info | |
| Storage | |
| Supplier Company |
service@interlab.com.tw +886-2-2736-7100 opens: 09:00-17:00 (weekdays)
卓昇有限公司-最專業科學研究供應商
卓昇有限公司–最專業科學研究供應商
CERV-196 (ABC-TC0131)
The CERV-196 cell line was established from a poorly differentiated squamous cell carcinoma of the cervix; HPV-16 positive. In vitro established from the xenotransplant cervix carcinoma MRI-H-196 by Cell Lines Service. Primary xenotransplant was adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.
